Amylyx Pharmaceuticals (AMLX) Prepaid Assets (2021 - 2026)

Amylyx Pharmaceuticals has reported Prepaid Assets for 6 years, with the latest figure at $5.6 million in Q2 2026.

• On a quarterly basis, Prepaid Assets fell 6.43% year-over-year to $5.6 million in Q2 2026; TTM through Jun 2026 was $5.6 million, a 6.43% decrease from a year earlier, with the FY2025 full-year figure at $6.7 million, down 46.4% from the prior year.
• Prepaid Assets was $5.6 million for Q2 2026 at Amylyx Pharmaceuticals, up from $5.3 million in the prior quarter.
• The five-year high for Prepaid Assets was $17.3 million in Q3 2023, with the low at $5.3 million in Q1 2026.
• Average Prepaid Assets over 5 years is $10.6 million, with a median of $10.2 million recorded in 2022.
• The sharpest annual moves came in 2023 and 2026: Prepaid Assets jumped 107.99% in 2023, then slumped 55.37% in 2026.
• Over 5 years, Prepaid Assets stood at $10.1 million in 2022, then jumped by 47.64% to $14.9 million in 2023, then fell by 16.39% to $12.5 million in 2024, then slumped by 46.4% to $6.7 million in 2025, then retreated by 16.65% to $5.6 million in 2026.
• The last three Prepaid Assets figures came in at $5.6 million (Q2 2026), $5.3 million (Q1 2026), and $6.7 million (Q4 2025), per Business Quant data.